Malaria-Causing Plasmodium in Uganda Show Rapid Spread of Drug Resistance Mutations
Researchers identified rapidly spreading genetic mutations in Ugandan malaria parasites linked to reduced susceptibility to artemisinin, lumefantrine, and mefloquine, offering new markers for resistance surveillance. The post Malaria-Causing Plasmodium in Uganda Show Rapid Spread of Drug Resistance Mutations appeared first on GEN - Genetic Engineering and Biotechnology News .
Malaria treatment in Uganda faces a growing threat as drug-resistant Plasmodium falciparum mutations spread rapidly. Researchers sequenced the genomes of drug-resistant parasites from hundreds of infected individuals, discovering specific genetic mutations associated with reduced susceptibility to key antimalarial drugs. These mutations, particularly in the phosphoinositide-binding protein (PX1), could significantly impact the effectiveness of the primary treatment, artemether-lumefantrine (AL), and other malaria drugs.
Researchers stress the urgent need for surveillance systems to monitor these mutations and develop new treatments to counteract the resistance.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.